David Itamar 4
4 · Enox Biopharma Inc · Filed Jun 24, 2010
Insider Transaction Report
Form 4
David Itamar
Chief Financial Officer
Transactions
- Award
Option (right to buy)
2010-02-15+1,000,000→ 1,000,000 totalExercise: $0.45Exp: 2020-02-15→ Common Stock (1,000,000 underlying)
Holdings
- 299,361
Common Stock
- 142,857
Option (right to buy)
Exercise: $0.20From: 2008-12-25Exp: 2011-12-25→ Common Stock (142,857 underlying)
Footnotes (3)
- [F1]Options granted under Memorandum of Agreement (MofA) between Issuer and Reporting Person dated Feb 15, 2010,. The vesting schedule is (certain terms used below have definitions in the Mof A): (i) 1/36th of option shares (27,778 shares, and the last month 27,770) vest every month following the date of the MofA; and (ii) All the options vest upon a change of control or in certain circumstances when Mr. David resigns.
- [F2]The options expire 10 years from the date of the MofA.
- [F3]The Reporting Person disclaims beneficial ownership of shares owned by his wife, Hadas David.